Connelly Stephen
President and CSO at EQ
- Sold, on record
- $3.4M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jun 5, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EQEquillium, Inc.President and CSO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale EQPlan not statedJul 13, 2020 2020
Sold 250,000 shares at $8.13 ($2M)
Connelly Stephen, Chief Scientific Officer
Sold 19.3% of holdings ($10.5M position)1M shares leftFirst sale on recordFiling
- 2 Form 4 sale EQPlan not statedSep 28, 2020 +77 days
Sold 25,000 shares at $5.62 ($141k)
Connelly Stephen, Chief Scientific Officer
Sold 2.4% of holdings ($5.9M position)1M shares leftFiling
- 3 Form 4 sale EQPlan not statedDec 28, 2020 +91 days
Sold 25,000 shares at $4.52 ($113k)
Connelly Stephen, Chief Scientific Officer
Sold 2.5% of holdings ($4.6M position)993,000 shares leftFiling
- 4 Form 4 sale EQPlan not statedJun 8, 2021 +162 days
Sold 46,424 shares at $7.10 ($330k)
Connelly Stephen, Chief Scientific Officer
Sold 4.5% of holdings ($7.4M position)993,000 shares left1.9x usual sizeFiling
- 5 Form 4 sale EQPlan not statedOct 6, 2021 +120 days
Sold 8,092 shares at $7.01 ($57k)
Connelly Stephen, Chief Scientific Officer
Sold 0.8% of holdings ($7M position)993,000 shares left0.2x usual sizeFiling
- 6 Form 4 sale EQNo planJun 5, 2026 +1703 days
Sold 230,975 shares at $3.13 ($723k)
Connelly Stephen, President and CSO
No 10b5-1 planSold 23.3% of holdings ($3.1M position)762,025 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 5, 2026 | EQ | President and CSO | Form 4 sale | 230,975 | $723k | 23.3% | No plan | SEC |
| Oct 6, 2021 | Oct 7, 2021 | EQ | Chief Scientific Officer | Form 4 sale | 8,092 | $57k | 0.8% | Plan not stated | SEC |
| Jun 8, 2021 | Jun 9, 2021 | EQ | Chief Scientific Officer | Form 4 sale | 46,424 | $330k | 4.5% | Plan not stated | SEC |
| Dec 28, 2020 | Dec 30, 2020 | EQ | Chief Scientific Officer | Form 4 sale | 25,000 | $113k | 2.5% | Plan not stated | SEC |
| Sep 28, 2020 | Sep 30, 2020 | EQ | Chief Scientific Officer | Form 4 sale | 25,000 | $141k | 2.4% | Plan not stated | SEC |
| Jul 13, 2020 | Jul 15, 2020 | EQ | Chief Scientific Officer | Form 4 sale | 250,000 | $2M | 19.3% | Plan not stated | SEC |